Emanuele Porazzi

Emanuele Porazzi

Auto-generated profile, based on publicly available information

Emanuele Porazzi

Healthcare Datascience Lab - HD LAB, LIUC-Università Cattaneo - Corso G. Matteotti, Castellanza, Italy

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2014 in Insights into Imaging
Verified
Journal Article
Open access
PDF file
Giovanni MauriGiovanni Mauri
Giovanni Mauri
EPEmanuele Porazzi
Emanuele Porazzi
LCLuca Cova
Luca Cova
URUmberto Restelli
Umberto Restelli
TTTania Tondolo
Tania Tondolo
Luigi Alessandro SolbiatiLuigi Alessandro Solbiati
Luigi Alessandro Solbiati
Objectives To assess the clinical and the economic impacts of intraprocedural use of contrast-enhanced ultrasound (CEUS) in patients undergoing percutaneous radiofrequency ablation for small (<2.5 cm) hepatocellular carcinomas. Methods One hundred and forty-eight hepatocellular carcinomas in 93 patients were treated by percutaneous radiofrequency ablation and immediate assessment by intraprocedural CEUS. Clinical impact, cost effectiveness, and budget, organisational and equity impacts were evaluated and compared with standard treatment without intraprocedural CEUS using the health technology assessment approach. Results Intraprocedural CEUS detected incomplete ablation in 34/93 (36.5 %) patients, who underwent additional treatment during the same session. At 24-h, complete ablation was found in 88/93 (94.6 %) patients. Thus, a second session of treatment was spared in 29/93 (31.1 %) patients. Cost-effectiveness analysis revealed an advantage for the use of intraprocedural CEUS in comparison with standard treatment (4,639 vs 6,592) with a 21.9 % reduction of the costs to treat the whole sample. Cost per patient for complete treatment was € 4,609 versus € 5,872 respectively. The introduction of intraprocedural CEUS resulted in a low organisational impact, and in a positive impact on equity Conclusions Intraprocedural use of CEUS has a relevant clinical impact, reducing the number of re-treatments and the related costs per patient. Teaching Points • CEUS allows to immediately asses the result of ablation. • Intraprocedural CEUS decreases the number of second ablative sessions. • Intraprocedural CEUS may reduce cost per patient for complete treatment. • Use of intraprocedural CEUS may reduce hospital budget. • Its introduction has low organisational impact, and relevant impact on equity.

1 August 2014 in The Spine Journal
Verified
Journal Article
Closed access
FCFrancesco Costa
Francesco Costa
EPEmanuele Porazzi
Emanuele Porazzi
URUmberto Restelli
Umberto Restelli
EFEmanuela Foglia
Emanuela Foglia
ACAndrea Cardia
Andrea Cardia
Giuseppe BanfiGiuseppe Banfi
Giuseppe Banfi

1 July 2011 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Closed access
GRGiuliano Rizzardini
Giuliano Rizzardini
URUmberto Mecon Restelli
Umberto Mecon Restelli
PBPaolo Bonfanti
Paolo Bonfanti
EPEmanuele Mecon Porazzi
Emanuele Mecon Porazzi
RERicci, Elena
Ricci, Elena
DCDavide Meng Croce
Davide Meng Croce
Background: Healthcare expenditures incurred by the Health Service for HIV-infected patients have not been reported in Italy. Objective: To present health care costs for HIV-infected patients in the Lombardy Region, in 2004-2007, to determine the clinical characteristics of HIV infection associated with costs. Methods: Retrospective, observational, budget impact study, based on information collected for the period 2004-2007, including hospitalizations, outpatient services, highly active antiretroviral therapy (HAART) and non-HAART drug utilization. Inclusion criteria includes: confirmed HIV infection, age ≥18 years, resident in Lombardy Region, and followed at the “L. Sacco” Hospital in Milan from 2004 to 2007. Results: The mean total cost per year to provide healthcare to HIV-positive patients was rather stable (€9658.36 in 2004 and €9745.65 in 2007 (+0.90%)); HAART represented more than 60% of the total cost. We found that hepatitis C virus coinfection was related to higher costs (€11,003.45 vs. €8896.06), as well as CD4 cell count <200 cells/mm3 (€12,681.36 vs. €9594.11 and €9450.36 in 200-499 and ≥500 cells/mm3, respectively). The mean total cost of HIV health care was higher in patients who initiated antiretroviral treatment before 1997 than in those who started after 1996. Conclusions: The mean total cost per year to provide health care to HIV-positive patients was stable during the period 2004-2007, with an increase of HAART percentage impact on the total cost. Several clinical characteristics of HIV-infected patients were significantly associated with cost variation.

1 March 2010 in Acta Tropica
Verified
Journal Article
Closed access
DCDavide Croce
Davide Croce
EPEmanuele Porazzi
Emanuele Porazzi
EFEmanuela Foglia
Emanuela Foglia
URUmberto Restelli
Umberto Restelli
MSMuth Sinuon
Muth Sinuon
AMAntonio Montresor
Antonio Montresor

12 November 2012 in Thrombosis Research
Verified
Journal Article
Closed access
PDF file
GGGualberto Gussoni
Gualberto Gussoni
EFEmanuela Foglia
Emanuela Foglia
AFAndrea Fontanella
Andrea Fontanella
LCLuca Casartelli
Luca Casartelli
MCMauro Campanini
Mauro Campanini
AMAntonino Mazzone
Antonino Mazzone

3 May 2017 in Health Economics Review
Verified
Journal Article
Open access
PDF file
COClaudia Ottardi
Claudia Ottardi
ADAlessio Damonti
Alessio Damonti
EPEmanuele Porazzi
Emanuele Porazzi
EFEmanuela Foglia
Emanuela Foglia
LFLucrezia Ferrario
Lucrezia Ferrario
FGFabio Galbusera
Fabio Galbusera
Lumbar arthrodesis is a common surgical technique that consists of the fixation of one or more motion segments with pedicle screws and rods. However, spinal surgery using these techniques is expensive and has a significant impact on the budgets of hospitals and Healthcare Systems. While reusable and disposable instruments for laparoscopic interventions have been studied in literature, no specific information exists regarding instrument kits for lumbar arthrodesis. The aim of the present study was to perform a complete health technology assessment comparing a disposable instrument kit for lumbar arthrodesis (innovative device) with the standard reusable instrument. A prospective and observational study was implemented, by means of investigation of administrative records of patients undergoing a lumbar arthrodesis surgical procedure. The evaluation was conducted in 2013, over a 12- month time horizon, considering all the procedures carried out using the two technologies. A complete health technology assessment and a multi-criteria decision analysis approach were implemented in order to compare the two alternative technologies. Economic impact (with the implementation of an activity based costing approach), social, ethical, organisational, and technology-related aspects were taken into account. Although the cost analysis produced similar results in the comparison of the two technologies (total cost equal to € 4,279.1 and € 4,242.6 for reusable instrument kit and the disposable one respectively), a significant difference between the two instrument kits was noted, in particular concerning the organisational impact and the patient safety. The replacement of a reusable instrument kit for lumbar arthrodesis, with a disposable one, could improve the management of this kind of devices in hospital settings.